Literature DB >> 30904478

Opioid-like antinociceptive and locomotor effects of emerging fentanyl-related substances.

Neil B Varshneya1, D Matthew Walentiny1, Lea T Moisa1, Teneille D Walker2, Luli R Akinfiresoye2, Patrick M Beardsley3.   

Abstract

The emergence of several fentanyl-related substances in the recreational drug marketplace has resulted in a surge of opioid overdose deaths in the United States. Many of these substances have never been examined in living organisms under controlled conditions. In the present study, seven fentanyl-related substances were tested in adult male Swiss Webster mice for their effects on locomotion and antinociception and compared to those of fentanyl and morphine. In locomotor activity tests, fentanyl (1, 10 mg/kg), morphine (100, 180 mg/kg), isobutyrylfentanyl (10 mg/kg), crotonylfentanyl (10 mg/kg), para-fluorobutyrylfentanyl (10, 100 mg/kg), para-methoxybutyrylfentanyl (10 mg/kg), thiophenefentanyl (100 mg/kg), and benzodioxolefentanyl (0.1 mg/kg) produced significant (p ≤ 0.05) dose-dependent increases in locomotion. Valerylfentanyl, however, was without effects on locomotion up to 100 mg/kg. In warm-water tail-withdrawal tests, all substances produced significant (p ≤ 0.05) dose-dependent increases in antinociception with increasing ED50 values (CI) of isobutyrylfentanyl [0.0768 mg/kg (0.044-0.128)] > fentanyl [0.0800 mg/kg (0.0403-0.164)] > para-methoxybutyrylfentanyl [0.106 mg/kg (0.0516-0.195)] > crotonylfentanyl [0.226 mg/kg (0.176-0.292)] > para-fluorobutyrylfentanyl [0.908 mg/kg (0.459-1.58)] > thiophenefentanyl [4.66 mg/kg (3.65-5.95)] > valerylfentanyl [6.43 mg/kg (3.91-10.5)] > morphine [7.82 mg/kg (5.42-11.0)] > benzodioxolefentanyl [46.3 mg/kg (25.8-83.4)]. Naltrexone (1 mg/kg) increased antinociceptive ED50 values several fold in decreasing magnitudes of isobutyrylfentanyl (233x) > para-methoxybutyrylfentanyl (37.7x) > thiophenefentanyl (34.6x) > valerylfentanyl (11.9x) > para-fluorobutyrylfentanyl (10.9x) > benzodioxolefentanyl (8.42x) > crotonylfentanyl (6.27x) > fentanyl (3.95x) > morphine (1.48x). These findings establish that locomotor and antinociceptive effects of several fentanyl-related substances are similar to those of morphine and fentanyl and are mediated by opioid receptors.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Analgesia; Analog; Fentanyl; Locomotion; Mice; Opioid

Mesh:

Substances:

Year:  2019        PMID: 30904478      PMCID: PMC8992608          DOI: 10.1016/j.neuropharm.2019.03.023

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  32 in total

1.  Fentanyl analogues with a modified propanamido group as potential affinity labels: synthesis and in vivo activity.

Authors:  M Y Essawi
Journal:  Pharmazie       Date:  1999-04       Impact factor: 1.267

2.  Oxycodone-like discriminative stimulus effects of fentanyl-related emerging drugs of abuse in mice.

Authors:  D Matthew Walentiny; Léa T Moisa; Patrick M Beardsley
Journal:  Neuropharmacology       Date:  2019-02-05       Impact factor: 5.250

3.  Evaluation of new compounds for opioid activity: 1986 annual report.

Authors:  J H Woods; C B Smith; F Medzihradsky; G D Winger; D E Gmerek
Journal:  NIDA Res Monogr       Date:  1987

4.  Dependence studies of new compounds in the rhesus monkey, rat and mouse (1986).

Authors:  M D Aceto; E R Bowman; L S Harris; E L May
Journal:  NIDA Res Monogr       Date:  1987

Review 5.  The neural basis of drug craving: an incentive-sensitization theory of addiction.

Authors:  T E Robinson; K C Berridge
Journal:  Brain Res Brain Res Rev       Date:  1993 Sep-Dec

6.  The analytical challenges of cyclopropylfentanyl and crotonylfentanyl: An approach for toxicological analysis.

Authors:  Shane Maher; Simon P Elliott; Steve George
Journal:  Drug Test Anal       Date:  2018-06-29       Impact factor: 3.345

7.  Increases in Drug and Opioid-Involved Overdose Deaths - United States, 2010-2015.

Authors:  Rose A Rudd; Puja Seth; Felicita David; Lawrence Scholl
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-12-30       Impact factor: 17.586

8.  Increases in Fentanyl-Related Overdose Deaths - Florida and Ohio, 2013-2015.

Authors:  Alexis B Peterson; R Matthew Gladden; Chris Delcher; Erica Spies; Amanda Garcia-Williams; Yanning Wang; John Halpin; Jon Zibbell; Carolyn Lullo McCarty; Jolene DeFiore-Hyrmer; Mary DiOrio; Bruce A Goldberger
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-08-26       Impact factor: 17.586

9.  Fentanyl Law Enforcement Submissions and Increases in Synthetic Opioid-Involved Overdose Deaths - 27 States, 2013-2014.

Authors:  R Matthew Gladden; Pedro Martinez; Puja Seth
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-08-26       Impact factor: 17.586

Review 10.  Misuse of Novel Synthetic Opioids: A Deadly New Trend.

Authors:  Matthew P Prekupec; Peter A Mansky; Michael H Baumann
Journal:  J Addict Med       Date:  2017 Jul/Aug       Impact factor: 3.702

View more
  14 in total

1.  Agonist that activates the µ-opioid receptor in acidified microenvironments inhibits colitis pain without side effects.

Authors:  Nestor Nivardo Jiménez-Vargas; Yang Yu; Dane D Jensen; Diana Daeun Bok; Matthew Wisdom; Rocco Latorre; Cintya Lopez; Josue O Jaramillo-Polanco; Claudius Degro; Mabel Guzman-Rodriguez; Quentin Tsang; Zachary Snow; Brian L Schmidt; David E Reed; Alan Edward Lomax; Kara Gross Margolis; Christoph Stein; Nigel W Bunnett; Stephen J Vanner
Journal:  Gut       Date:  2021-03-30       Impact factor: 23.059

2.  Opioid-like adverse effects of tianeptine in male rats and mice.

Authors:  T R Baird; H I Akbarali; W L Dewey; H Elder; M Kang; S A Marsh; M R Peace; J L Poklis; E J Santos; S S Negus
Journal:  Psychopharmacology (Berl)       Date:  2022-02-24       Impact factor: 4.530

3.  Respiratory depressant effects of fentanyl analogs are opioid receptor-mediated.

Authors:  Neil B Varshneya; Sherif H Hassanien; Melissa C Holt; David L Stevens; Nathan K Layle; Jonathon R Bassman; Donna M Iula; Patrick M Beardsley
Journal:  Biochem Pharmacol       Date:  2021-10-19       Impact factor: 6.100

4.  Role of Efficacy as a Determinant of Locomotor Activation by Mu Opioid Receptor Ligands in Female and Male Mice.

Authors:  Edna J Santos; Matthew L Banks; S Stevens Negus
Journal:  J Pharmacol Exp Ther       Date:  2022-04-30       Impact factor: 4.402

5.  Confronting the opioid crisis with basic research in neuropharmacology.

Authors:  Michael H Baumann; Gavril W Pasternak; Sidney S Negus
Journal:  Neuropharmacology       Date:  2020-01-17       Impact factor: 5.250

6.  Mitragynine improves cognitive performance in morphine-withdrawn rats.

Authors:  Chiek Yi You; Zurina Hassan; Christian P Müller; Farah Wahida Suhaimi
Journal:  Psychopharmacology (Berl)       Date:  2021-10-25       Impact factor: 4.530

7.  Fentanyl-related substances elicit antinociception and hyperlocomotion in mice via opioid receptors.

Authors:  Neil B Varshneya; D Matthew Walentiny; Lea T Moisa; Teneille D Walker; Luli R Akinfiresoye; Patrick M Beardsley
Journal:  Pharmacol Biochem Behav       Date:  2021-07-21       Impact factor: 3.697

8.  Fentanyl depression of respiration: Comparison with heroin and morphine.

Authors:  Rob Hill; Rakulan Santhakumar; William Dewey; Eamonn Kelly; Graeme Henderson
Journal:  Br J Pharmacol       Date:  2019-12-23       Impact factor: 8.739

9.  Aversion-resistant fentanyl self-administration in mice.

Authors:  Sean C Monroe; Anna K Radke
Journal:  Psychopharmacology (Berl)       Date:  2020-11-23       Impact factor: 4.530

Review 10.  Preclinical Evaluation of Vaccines to Treat Opioid Use Disorders: How Close are We to a Clinically Viable Therapeutic?

Authors:  E Andrew Townsend; Matthew L Banks
Journal:  CNS Drugs       Date:  2020-05       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.